FDA cannabis cmte. lead talks cannabinoid products, rescheduling • How will NYC handle its enforcement load? • Germany’s legalization opponents question law • & more …
An excerpt from recent editions of the Cannabis Wire Daily newsletter.
House Lawmakers Push Top FDA Official on Hemp Products and Cannabis Rescheduling
The conversation covered the proliferation of intoxicating hemp products, as well as the timeline for the federal review of whether to move cannabis from Schedule I to III.
FDA Officials Discuss Future of Cannabis Regulation at Food & Drug Law Institute
The conversation ranged from Congressional inaction on CBD to the myriad unregulated cannabinoid products on shelves today.
FDA touts cannabis scheduling work in new report on priorities • In Ukraine, President Zelensky signs medical cannabis bill into law • & more …
An excerpt from recent editions of the Cannabis Wire Daily newsletter.
FDA Looks Back On Fifty Years of Cannabis Research, Prepares for Growth Ahead
FDA researchers published an article this week titled “From Our Perspective: FDA’s 50 Years of Experience with Cannabis Research Helping to Support Tomorrow’s Cannabis Drug Development.”
Cannabis comes up at FDA listening session on tobacco • A GOP pushback on rescheduling • NY lawmakers push Hochul on tribal sales bill • & more …
An excerpt from recent editions of the Cannabis Wire Daily newsletter.
Congressional Research Service pubs primer on the FDA, hemp • RFI on CBD closed. Here’s a look at submissions • New York litigation latest • & more …
An excerpt from recent editions of the Cannabis Wire Daily newsletter.
Congress Picks Up the Baton from the FDA on CBD, Seeking Data
The unregulated hemp-derived cannabinoid marketplace has exploded since the 2018 Farm Bill descheduled hemp. The FDA has asked Congress to help with a “new regulatory pathway.”
NHTSA to ramp up DRE data collection • Virginia regulators prep for medical cannabis market study • FDA issues delta-8 THC warnings • & more …
An excerpt from recent editions of the Cannabis Wire Daily newsletter.